id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-345827-yo3uq03v	Antiochia, Riccarda	Developments in biosensors for CoV detection and future trends	2020-10-28		.txt	text/plain	5968	278	44	Since MERS and COVID-19 are highly contagious diseases with the potential to cause a pandemic, in absence of a specific vaccine or effective therapeutic drugs, it is of extreme importance to find rapid and accurate detection methods for control and prevention of virus spread. Current methods used for screening and diagnosis of novel COVID-19 are based on three different approaches: SARS-CoV-2 antigen detection in nasopharyngeal secretions through molecular biology techniques, computed tomography, and SARS-CoV-2 antibody analysis in serum using immunoassay methods (Carter et al., 2020) . According to the Food and Drug Administration (FDA) Emergency Use Authorizations (EUAs) for COVID-19 diagnostics, in addition to the most common ELISA method, there are two serological assays used for the detection of antibodies generated against SARS-CoV-2, the chemiluminescence immunoassays (CLIA) and the lateral flow immunoassays (LFIA). Biosensors based on specific biomolecular interactions offer an alternative and reliable solution to current methods for clinical diagnosis of COVID-19, due to their high sensitivity, low-cost, easy to use and possibility of POC utilization.	./cache/cord-345827-yo3uq03v.txt	./txt/cord-345827-yo3uq03v.txt